Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Research Collaboration Agreement

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Research Collaboration Agreement

Entities:

Lynx Therapeutics, Inc.; Pioneer Hi Bred International Inc.; E.I. Dupont de Nemours and Co.

Date:

2001

Size:

Preview shows 7KB of 85KB total

Price:

$45

ID:

#279353

 

 

► Licensing ► Collaboration ► Research Collaboration Agreements
► Biotech & Drugs ► Medicinal Chemicals & Botanical Products

 

 

Start of Preview


                        RESEARCH COLLABORATION AGREEMENT




THIS RESEARCH COLLABORATION AGREEMENT ("Agreement") dated as of October
29, 1998 (the "Effective Date"), is made by and between LYNX THERAPEUTICS, INC.
a Delaware corporation ("Lynx"), and E.I. DUPONT DE NEMOURS AND CO., a Delaware
corporation ("DuPont"). Lynx and DuPont are sometimes referred to herein
individually as a "Party" and collectively as the "Parties".

RECITALS

WHEREAS, Lynx owns or controls certain technology and intellectual
property rights relating to solid phase cloning on beads of genomic DNA or cDNA
and analytical applications thereof, such as bead-based library comparisons,
signature sequencing on beads and high resolution physical mapping; and

WHEREAS, DuPont is actively researching, developing and commercializing
products for agricultural applications; and

WHEREAS, the Parties wish to establish a collaboration applying such
Lynx technology to the study of certain crop plants, to enable the discovery,
development and commercialization of agricultural products applicable to such
plants, including without limitation pesticides for the protection of such plant
crops as well as other agricultural chemical applications; and

WHEREAS, in connection with establishing such collaboration DuPont
wishes to obtain and Lynx is willing to grant to DuPont certain license rights
to Lynx's technology as described more fully herein, under the terms and
conditions set forth in this Agreement;

NOW, THEREFORE, in consideration of the foregoing recitals and the
mutual covenants and agreements contained herein, the Parties hereto, intending
to be legally bound, agree as follows:

ARTICLE 1

DEFINITIONS

As used in this Agreement, the following terms shall have the meanings
set forth below:

1.1 "AFFILIATE" shall mean any entity that directly or indirectly Owns,
is Owned by or is under common Ownership with, a party to this Agreement, where
"Own" or "Ownership" means direct or indirect possession of at least fifty
percent (50%) of the outstanding voting securities of a corporation or a
comparable ownership in any other type of entity, provided, however, that if the
law of the jurisdiction in which such entity operates does not allow fifty
percent (50%) or greater ownership by a party to this Agreement, such ownership
interest shall be at least forty percent (40%). For purposes of this Agreement,
Pioneer Hi-Bred International Inc. of Des Moines, Iowa, in which DuPont has a
twenty percent (20%) ownership interest, shall be considered a DuPont Affiliate.

1.2 "CO-EXCLUSIVE CROPS" shall mean all varieties, whether known as of
the Effective Date or hereafter created, of any of the following: [ * ].

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS
AMENDED.

{PAGE} 3

1.3 "COLLABORATIVE EFFORT" shall mean research and development
undertaken jointly in the Field by the parties based upon plans and projects
mutually agreed by the Joint Research Committee.

1.4 "CO-EXCLUSIVE FIELD" shall mean the analysis of genomes and gene
expression of Co-Exclusive Crops, for the purpose of developing and
commercializing products solely for use in commercial agricultural applications
with respect to one or more Co-Exclusive Crops, including but not limited to
protection of such Co-Exclusive Crops against pests, improvement of the growth,
yield, disease resistance or other characteristics of the Co-Exclusive Crops or
for other agricultural purposes and agricultural chemical products relating to
the Co-Exclusive Crops.

1.5 "COLLABORATION TERM" shall mean the period commencing on the
Effective Date and continuing until the fifth anniversary of the Effective Date,
unless earlier terminated or extended under this Agreement.

1.6 "CONFIDENTIAL INFORMATION" shall mean, with respect to a Party, any
Information disclosed by such Party to the other Party under this Agreement,
except as limited by Section 8.2.

1.7 "[ * ] MAP" shall have the meaning set forth in Section 3.7(a).

1.8 "CROPS" shall mean the Exclusive Crops, the Co-Exclusive Crops and
the Non-Exclusive Crops.

1.9 "EXCLUSIVE CROPS" shall mean all varieties, whether known as of the
Effective Date or hereafter created, of any of the following: [ * ].

1.10 "EXCLUSIVE FIELD" shall mean the analysis of genomes and gene
expression of Exclusive Crops, for the purpose of developing and commercializing
products solely for use in commercial agricultural applications with respect to
one or more Exclusive Crops, including but not limited to protection of such
Exclusive Crops against pests, improvement of the growth, yield, disease
resistance or other characteristics of the Exclusive Crops or for other
agricultural purposes and agricultural chemical products relating to the
Exclusive Crops.

1.11 "EXPERIMENTS" shall mean those experiments, as further described in
Sections 3.2 and 3.3, that are intended to apply the Lynx Technology to
commercial research relating to the Crops to enable discovery and development of
agricultural products useful for protection of such Crops against pests,
improvement of the growth, yield, disease resistance or other characteristics of
the Crops of for other agricultural purposes relating to the Crops.

1.12 "FIELD" shall mean the analysis of genomes and gene expression of
plants, or of plant pathogens or plant pests, for the purpose of developing and
commercializing Products solely for use in commercial agricultural applications
with respect to one or more plants, including but not limited to protection of
plants against pests, improvement of the growth, yield, disease resistance or
other characteristics of plants or for other agricultural purposes and
agricultural chemical products relating to plants.

1.13 "HRP MAP" shall have the meaning set forth in Section 3.7(c).

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC